PREMUROSA Project

Company Description

Musculoskeletal diseases are a major burden on individuals, healthcare and welfare systems. Treatment of musculoskeletal disorders is currently based either on prosthetic or regenerative surgical procedures, often involving medical device implantation. In both cases, individual tissue healing and regeneration, together with the appropriateness of the implanted device, markedly affect the outcome. A great improvement could be achieved by precision medicine, specifically designed on patient's individual characteristics. This implies to combine the personalized clinical approach with individual ‘omic' characterization and proper choice of medical device. The concept is "To take care with care". This is the meaning of the Italian word "premurosa" and the ultimate goal of the ITN PREMUROSA project, aimed to train a new generation of scientists with an integrated vision of the whole value chain in musculo-skeletal regeneration technologies and able to boost the necessary innovations to achieve precision principles in developing innovative devices and optimized clinical applications. This aim will be achieved by a "triple i" (interdisciplinary, intersectoral, international) approach of thirteen ESRs, who will benefit from an excellent scientific environment, up-date technologies and supervision by international leaders in the field. They will learn to integrate academic and industrial aspects and will sharpen their experimental and complementary skills in a well-designed and diversified and unprecedented training program. PREMUROSA has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 860462